Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Author(s): Lisa Brandon , Faisal Sharif Added: 3 years ago
Resistant hypertension remains a serious clinical burden despite significant advances in cardiology and healthcare. Hypertension is a chronic condition without any available cure, with significant associated morbidity and mortality, and necessitates lifelong use of medications. It is multifactorial in origin, associated with genetics, lifestyle factors and the metabolic syndrome. Resistant… View more

Prevention & Chronic Conditions

Intervention
Anticoagulant Therapy for Acute Coronary Syndromes
Author(s): Eunice NC Onwordi , Amr Gamal , Azfar Zaman Added: 3 years ago
Acute coronary syndromes (ACS) are a major cause of morbidity and mortality. Despite the use of optimal medical therapy and revascularisation there remains a significant risk of vascular events. Registry data indicates a persistent risk even in patients who are event free in the first year following ACS, with as many as 1 in 5 patients suffering a vascular event in the subsequent 3 years.1 The… View more

Anticoagulation

Prevention & Chronic Conditions
The goal of the CICT Conferences is to promote high quality, patient-centered, clinical and technical decision-making in the field of Interventional Cardiovascular Medicine. The uniqueness of the CICT conferences lies in the open forum transparent discussion of controversial topics allowing free flowing interaction between audience and faculty. The content of these meetings addresses a wide range… View more
Author(s): William R Colyer Jr , Christopher J Cooper Added: 3 years ago
Renal artery stenosis (RAS) is a common manifestation of atherosclerotic disease. Although the exact prevalence rate for the population as a whole is unknown, RAS is seen in a significant proportion of patients who present with another manifestation of atherosclerosis (Table 1).1–7 Despite this high degree of prevalence, the management of RAS, specifically the role of revascularisation, remains… View more

Vascular Disease and Surgery

Prevention & Chronic Conditions
BAROSTIM THERAPY for RHTN Physician Testimonial
Added: 5 years ago
BAROSTIM THERAPY for RHTN Physician Testimonial View more
Impella Support and Cardiac Gene Therapy for Heart Failure
Author(s): Roger J Hajjar Added: 6 years ago

Heart Failure
ISET 2024
Start date: Jan 22, 2024 End date: Jan 25, 2024
For 36 years and counting, the International Symposium on Endovascular Therapy (ISET) has served as the cornerstone for experts to convene and engage in discussions and deliberations regarding cutting-edge techniques, groundbreaking technologies, and innovative procedures that continually elevate the standard of patient care.ISET's 2024 scientific sessions consist of 4 days of endovascular… View more

Intervention
Improving Cardiac Gene Therapy Efficacy Using Impella
Author(s): Kiyotake Ishikawa Added: 4 years ago

MI/ACS
Supersaturated Oxygen (SSO2) Therapy in STEMI Treatments
Author(s): Dan Burkhoff , Sandeep Nathan , Jerry D Estep , et al Added: 2 years ago
Despite advances in reperfusion with primary stenting, progress in STEMI outcomes has stalled over the past 20 years. With 90% of coronary blood flow in the capillaries, the answer might be in the microvasculature. TherOx SSO2 Therapy is the first FDA approved therapy shown to significantly reduce the infarct size in STEMI patients. During this series of webinars on Supersaturated Oxygen … View more

MI/ACS

Intervention